Multivariant human IL-3 fusion proteins and their recombinant production
US6057133A · kind A · utility
11Cited by
12References
70Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 1994 |
| Grant date | May 2, 2000 |
| Priority date | — |
| Expiry date | Feb 4, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to fusion molecules composed of human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally joined to a second colony stimulating factor (CSF), cytokine, lymphokine, interleukin, hematopoietic growth factor or IL-3 variant. The invention also relates to pharmaceutical compositions containing the fusion molecules and methods for using them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.